Hypervirulent Klebsiella pneumoniae ST23: Hypervirulence Meets Antimicrobial Resistance

Abstract

Hypervirulent Klebsiella pneumoniae can cause community-acquired invasive infections such as pyogenic liver abscess and endophthalmitis in healthy individuals compared to the classical K. pneumoniae, causing opportunistic healthcare-associated infections. Globally, K. pneumoniae clonal group 23, including sequence type (ST) 23, is the dominant clone causing hypervirulent invasive infections. K. pneumoniae ST23 clones harbor capsular serotype K1, together with hypervirulence-associated genes such as ybt, iuc, iro, rmpA, and rmpA2 encoded on hypervirulence plasmids, which can define the hypervirulence of K. pneumoniae ST23. Historically, antimicrobial resistance (AMR) has not been associated with K. pneumoniae ST23. However, the emergence of carbapenem-resistant K. pneumoniae ST23 has been reported from various countries, and regional clustering was reported, suggesting the spread of these strains globally. Genomic surveillance by whole-genome sequencing method should be implemented on a global scale to highlight the global and local trends in antimicrobial resistance and hypervirulence in K. pneumoniae ST23 clones.

Keywords

Klebsiella pneumoniae / hypervirulent / carbapenem-resistant / ST23

Author Contributions

A.T.: conceptualization, writing—original draft preparation and editing; L.K.S.: writing—reviewing and editing. Both authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

[1] European Centre for Disease Prevention and Control. Emergence of Hypervirulent Klebsiella pneumoniae ST23 Carrying Carbapenemase Genes in EU/EEA Countries. 17 March 2021. ECDC: Stockholm. 2021. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-20240129-48%20FINAL.pdf (accessed on 29 April 2025).

[2] European Centre for Disease Prevention and Control. Emergence of Hypervirulent Klebsiella pneumoniae ST23 Carrying Carbapenemase Genes in EU/EEA Countries, First Update. 14 February 2024. ECDC: Stockholm. 2024. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-20240129-48%20FINAL.pdf (accessed on 29 April 2025).

[3] World Health Organization.Disease Outbreak News; Antimicrobial Resistance, Hypervirulent Klebsiella pneumoniae—Global Situation. Available online: https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON527 (accessed on 29 April 2025).

[4] Ho C.S.; Wong C.T.H.; Aung T.T.; et al. Antimicrobial resistance: A concise update. Lancet Microbe 2025, 6, 100947.

[5] U.S. Centers for Disease Control and Prevention. Antimicrobial Resistance Threats in the United States, 2021-2022. Available online: https://www.cdc.gov/antimicrobial-resistance/data-research/threats/update-2022.html (accessed on 29 April 2025).

[6] Lin Y.T.; Siu L.K.; Lin J.C.; et al. Seroepidemiology of Klebsiella pneumoniae colonizing the intestinal tract of healthy Chinese and overseas Chinese adults in Asian countries. BMC Microbiol. 2012, 12, 13.

[7] Podschun R.; Ullmann U. Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 1998, 11, 589.

[8] Martin R.M.; Cao J.; Brisse S.; et al. Molecular epidemiology of colonizing and infecting isolates of Klebsiella pneumoniae. mSphere 2016, 1, e00261.

[9] Russo T.A.; Marr C.M. Hypervirulent Klebsiella pneumoniae. Clin. Microbiol. Rev. 2019, 32, e00001.

[10] Liu Y.C.; Cheng D.L.; Lin C.L. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch. Intern. Med. 1986, 146, 1913-1916.

[11] Shon A.S.; Bajwa R.P.; Russo T.A. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: A new and dangerous breed. Virulence 2013, 4, 107-118.

[12] Holt K.E.; Wertheim H.; Zadoks R.N.; et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc. Natl. Acad. Sci. USA 2015, 112, e3574-e3581.

[13] Bialek-Davenet S.; Criscuolo A.; Ailloud F.; et al. Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg. Infect. Dis. 2014, 20, 1812-1820.

[14] Wyres K.L.; Lam M.M.C.; Holt K.E. Population genomics of Klebsiella pneumoniae. Nat. Rev. Microbiol. 2020, 18, 344-359.

[15] Brisse S.; Fevre C.; Passet V.; et al. Virulent clones of Klebsiella pneumoniae: Identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS ONE 2009, 4, e4982.

[16] Liao C.H.; Huang Y.T.; Chang C.Y.; et al. Capsular serotypes and multilocus sequence types of bacteremic Klebsiella pneumoniae isolates associated with different types of infections. Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33, 365-369.

[17] Wyres K.L.; Nguyen T.N.T.; Lam M.M.C.; et al. Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia. Genome Med. 2020, 12, 11.

[18] Fang C.T.; Lai S.Y.; Yi W.C.; et al. Klebsiella pneumoniae genotype K1: An emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin. Infect. Dis. 2007, 45, 284-293.

[19] Maguire M.; DeLappe N.; Clarke C.; et al. Genomic and phylogenetic analysis of hypervirulent Klebsiella pneumoniae ST23 in Ireland. Microb. Genom. 2025, 11, 1-11.

[20] Lam M.M.C.; Wyres K.L.; Duchêne S.; et al. Population genomics of hypervirulent Klebsiella pneumoniae clonal-group 23 reveals early emergence and rapid global dissemination. Nat. Commun. 2018, 9, 2703.

[21] Russo T.A.; Olson R.; Fang C.T.; et al. Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J. Clin. Microbiol. 2018, 56, e00776-18.

[22] Tang Y.; Du P.; Du C.; et al. Genomically defined hypervirulent Klebsiella pneumoniae contributed to early-onset increased mortality. Nat. Commun. 2025, 16, 2096.

[23] Cejas D.; Fernández Canigia L.; Rincón Cruz G.; et al. First isolate of KPC-2-producing Klebsiella pneumoniae sequence type 23 from the Americas. J. Clin. Microbiol. 2014, 52, 3483-3485.

[24] Gu D.; Dong N.; Zheng Z.; et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: A molecular epidemiological study. Lancet Infect. Dis. 2018, 18, 37-46.

[25] Shen D.; Ma G.; Li C.; et al. Emergence of a multidrug-resistant hypervirulent Klebsiella pneumoniae sequence type 23 strain with a rare blaCTX-M-24-harboring virulence plasmid. Antimicrob. Agents Chemother. 2019, 63, e02273-18.

[26] Yan R.; Lu Y.; Zhu Y.; et al. A sequence type 23 hypervirulent Klebsiella pneumoniae strain presenting carbapenem resistance by acquiring an IncP1 blaKPC-2 plasmid. Front. Cell Infect. Microbiol. 2021, 11, 641830.

[27] Baraniak A.; Grabowska A.; Izdebski R.; et al. Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009. Antimicrob. Agents Chemother. 2011, 55, 5493-5499.

[28] Karlsson M.; Stanton R.A.; Ansari U.; et al. Identification of a carbapenemase-producing hypervirulent Klebsiella pneumoniae isolate in the United States. Antimicrob. Agents Chemother. 2019, 63, e00519-19.

[29] Tu Y.; Gao H.; Zhao R.; et al. Molecular characteristics and pathogenic mechanisms of KPC-3 producing hypervirulent carbapenem-resistant Klebsiella pneumoniae (ST23-K1). Front. Cell. Infect. Microbiol. 2024, 14, 1407219.

[30] Gálvez-Silva M.; Arros P.; Berríos-Pastén C.; et al. Carbapenem-resistant hypervirulent ST23 Klebsiella pneumoniae with a highly transmissible dual-carbapenemase plasmid in Chile. Biol. Res. 2024, 57, 7.

[31] Yonekawa S.; Mizuno T.; Nakano R.; et al. Molecular and epidemiological characteristics of carbapenemase-producing Klebsiella pneumoniae clinical isolates in Japan. mSphere 2020, 5, e00490-20.

[32] Galway Reference Laboratory Service Users Guide. Available online: https://www.saolta.ie/sites/default/files/publications/NSSLRL%20%20CPERL%20User%20Guide_2025_1.pdf (accessed on 19 May 2025).

[33] David S.; Reuter S.; Harris S.R.; et al. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat. Microbiol. 2019, 4, 1919-1929.

[34] Raffelsberger N.; Hetland M.A.K.; Svendsen K.; et al. Gastrointestinal carriage of Klebsiella pneumoniae in a general adult population: A cross-sectional study of risk factors and bacterial genomic diversity. Gut Microbes 2021, 13, 1939599.

[35] Lam M.M.C.; Wick R.R.; Watts S.C.; et al. A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex. Nat. Commun. 2021, 12, 4188.